Covered recipient · General Payments record
PAUL J GAUSMAN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018
$202.42
- Reported across 15 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2018 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $202.42 | 15 |
By paying entity
PY2018 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $74.43 | 5 |
| PFIZER INC. | $51.41 | 4 |
| Merck Sharp & Dohme Corporation | $15.40 | 1 |
| Shire North American Group Inc | $13.66 | 1 |
| GlaxoSmithKline, LLC. | $12.82 | 1 |
| Amgen Inc. | $12.79 | 1 |
| Novo Nordisk AS | $10.97 | 1 |
| Lilly USA, LLC | $10.94 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2018 | $202.42 | 15 |
Payment records · PY2018 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $12.79 | 02/15/2018 | Food and Beverage | Undisputed | 01/23/2026 | 567828793 | CMS |
| Astellas Pharma US Inc | $19.28 | 01/18/2018 | Food and Beverage | Undisputed | 01/23/2026 | 582552847 | CMS |
| Astellas Pharma US Inc | $12.84 | 02/23/2018 | Food and Beverage | Undisputed | 01/23/2026 | 582672491 | CMS |
| Astellas Pharma US Inc | $13.82 | 03/15/2018 | Food and Beverage | Undisputed | 01/23/2026 | 582652241 | CMS |
| Astellas Pharma US Inc | $13.88 | 04/30/2018 | Food and Beverage | Undisputed | 01/23/2026 | 582651063 | CMS |
| Astellas Pharma US Inc | $14.61 | 05/08/2018 | Food and Beverage | Undisputed | 01/23/2026 | 582636597 | CMS |
| GlaxoSmithKline, LLC. | $12.82 | 02/12/2018 | Food and Beverage | Undisputed | 01/23/2026 | 593839085 | CMS |
| Lilly USA, LLC | $10.94 | 02/20/2018 | Food and Beverage | Undisputed | 01/23/2026 | 559617587 | CMS |
| Merck Sharp & Dohme Corporation | $15.40 | 05/21/2018 | Food and Beverage | Undisputed | 01/23/2026 | 604400121 | CMS |
| Novo Nordisk Inc | $10.97 | 03/06/2018 | Food and Beverage | Undisputed | 01/23/2026 | 587848921 | CMS |
| PFIZER INC. | $12.27 | 01/12/2018 | Food and Beverage | Undisputed | 01/23/2026 | 610366781 | CMS |
| PFIZER INC. | $12.89 | 02/14/2018 | Food and Beverage | Undisputed | 01/23/2026 | 610154307 | CMS |
| PFIZER INC. | $13.10 | 03/09/2018 | Food and Beverage | Undisputed | 01/23/2026 | 610291247 | CMS |
| PFIZER INC. | $13.15 | 06/19/2018 | Food and Beverage | Undisputed | 01/23/2026 | 610363907 | CMS |
| Shire North American Group Inc | $13.66 | 03/22/2018 | Food and Beverage | Undisputed | 01/23/2026 | 566113457 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018
- Source files
- Dataset page · Bulk file · PY2018
- Generated from
- OP_DTL_GNRL_PGYR2018_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.